Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

Phoenix

Sun City

Long Beach

San Diego

San Francisco

Delray Beach

Fort Myers

Lady Lake

Lake Worth

Merritt Island

Orlando

Port Orange

St. Petersburg

Weston

Atlanta

Decatur

Chicago

Elk Grove

Elk Grove Village

Iowa City

Farmington Hills

St Louis

Las Vegas

Marlton

New York

Concord

Durham

Akron

Portland

Charleston

Cordova

Houston

Salt Lake City

Middleton

North Ryde

Southport

West Heidelberg

Nedlands

Stuttgart

Siegen

Halle

Berlin

Basel

Exeter

Plymouth

Hammersmith

London

Manchester

Salford

Blackpool

Isleworth

Glasgow

Dundee

Perth

Bristol